PSYCHOTHERAPY WITH NIGHT-TERROR PATIENTSKALES JD; CADIEUX RJ; SOLDATOS CR et al.1982; AMERICAN JOURNAL OF PSYCHOTHERAPY; ISSN 0002-9564; USA; DA. 1982; VOL. 36; NO 3; PP. 399-407; BIBL. 13 REF.Article

HYPNOTIC EFFECTIVENESS OF SODIUM SALICYLAMIDE WITH SHORT-TERM USE: SLEEP LABORATORY STUDIES.SOLDATOS CR; KALES A; BIXLER EO et al.1978; PHARMACOLOGY; SWITZ.; DA. 1978; VOL. 16; NO 4; PP. 193-198; BIBL. 17 REF.Article

PREVALENCE OF SLEEP DISORDERS IN THE LOS ANGELES METROPOLITAIN AREABIXLER EO; KALES A; SOLDATOS CR et al.1979; AMER. J. PSYCHIATRY; USA; DA. 1979; VOL. 136; NO 10; PP. 1257-1262; BIBL. 21 REF.Article

SLEEPWALKING AND NIGHT TERRORS RELATED TO FEBRILE ILLNESSKALES JD; KALES A; SOLDATOS CR et al.1979; AMER. J. PSYCHIATRY; USA; DA. 1979; VOL. 136; NO 9; PP. 1214-1215; BIBL. 10 REF.Article

EFFECTS OF HYPNOTIC DRUGS ON MEMORYBIXLER EO; SCHARF MB; SOLDATOS CR et al.1979; LIFE SCI.; GBR; DA. 1979; VOL. 25; NO 16; PP. 1379-1388; BIBL. 27 REF.Article

LONG-TERM SLEEP LABORATORY EVALUATION OF FLUNITRAZEPAMSCHARF MB; BIXLER EO; KALES A et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 4; PP. 173-181; BIBL. 23 REF.Article

QUAZEPAM AND FLUAZEPAM: LONG-TERM USE AND EXTENDED WITHDRAWALKALES A; BIXLEX EO; SOLDATOS CR et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 6; PP. 781-788; BIBL. 26 REF.Article

SLEEP APNEIC ACTIVITY IN A NORMAL POPULATIONBIXLER EO; KALES A; SOLDATOS CR et al.1982; RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY; ISSN 0034-5164; USA; DA. 1982; VOL. 36; NO 1; PP. 141-152; BIBL. 2 P.Article

EFFECTS OF FLURAZEPAM (DALMANE) ON ANTERIOR PITUITARY SECRETION.BIXLER EO; KALES A; SANTEN R et al.1976; REV. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 14; NO 3; PP. 421-429; BIBL. 1 P.Article

NARCOLEPSY-CATAPLEXY. I: CLINICAL AND ELECTROPHYSIOLOGIC CHARACTERISTICSKALES A; CADIEUX RJ; SOLDATOS CR et al.1982; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 3; PP. 164-168; BIBL. 23 REF.Article

ONSET OF INSOMNIA: ROLE OF LIFE-STRESS EVENTSHEALEY ES; KALES A; MONROE LJ et al.1981; PSYCHOSOM. MED.; ISSN 0033-3174; USA; DA. 1981; VOL. 43; NO 5; PP. 439-451; BIBL. 39 REF.Article

NIGHT TERRORS: CLINICAL CHARACTERISTICS AND PERSONALITY PATTERNSKALES JD; KALES A; SOLDATOS CR et al.1980; ARCH. GEN. PSYCHIATRY; ISSN 0003-990X; USA; DA. 1980; VOL. 37; NO 12; PP. 1413-1417; BIBL. 15 REF.Article

QUAZEPAN, A NEW BENZODIAZEPINE HYPNOTIC: INTERMEDIATETERM SLEEP LABORATORY EVALUATIONKALES A; SCHARF MB; SOLDATOS CR et al.1980; J. CLIN. PHARMACOL.; USA; DA. 1980; VOL. 20; NO 4 PART. 1; PP. 184-192; BIBL. 21 REF.Article

NARCOLEPSY-CATAPLEXY. II: PSYCHOSOCIAL CONSEQUENCES AND ASSOCIATED PSYCHOPATHOLOGYKALES A; SOLDATOS CR; BIXLER EO et al.1982; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 3; PP. 169-171; BIBL. 20 REF.Article

DOSE-RESPONSE STUDIES OF QUAZEPAMKALES A; SCHARF MB; BIXLER EO et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 2; PP. 195-200; BIBL. 12 REF.Article

PROPANOLOL IN THE TREATMENT OF NARCOLEPSYKALES A; SOLDATOS CR; CADIEUX R et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 91; NO 5; PP. 741-743; BIBL. 10 REF.Article